IBD Patients, Originator Treatment, Biosimilar, Switch Back
1 clinical trials · Condition
◉ Watch IBD Patients, Originator Treatment, Biosimilar, Switch Back
| Record | Firm | Date |
|---|---|---|
| A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar (NCT04422171) | University Hospital, Grenoble | 2020-06-19 |
Track IBD Patients, Originator Treatment, Biosimilar, Switch Back automatically
Every clearance here is in the API, with alerts when new ones post.